Press Releases

Christie & Co to sell 5 north west pharmacies for Sykes Chemist Group

Specialist business property adviser, Christie & Co, has been instructed to sell five pharmacies located across Bolton and Accrington on behalf of Sykes Chemist Group.

Business. Built around You.

Your expert business property advisers

Tom Young

Tom Young

Business Agent - Medical

5 pharmacies in Bolton and Accrington, which are trading under Sykes Chemist Group

The group comprises four pharmacies in Bolton - Gatleys Pharmacy on Tonge Old Road, Haslams Pharmacy on Halliwell Road, Rigbys Chemist on Swan Lane, and Howards Pharmacy on Chorley Old Road – and Paradise Street Pharmacy within Pals Health Centre in Accrington. These well-established community pharmacies dispense a combined total of circa 33,000 items per month.

The pharmacies are part of a wider group of 14 branches owned by Sykes Chemist Group, which has decided to sell these branches as part of a strategic review of its portfolio.

Tom Young, Business Agent – Pharmacy at Christie & Co, who is handling the sale, comments, “We are delighted to have been engaged by the family of Sykes Chemist Group in this exciting disposal project of five north west pharmacies. Greater Manchester is a hotbed of buyer activity, especially for first and second-time buyers, so we expect a strong response from the market on this instruction.”

The group is up for sale on an individual, group, or sub-group basis. The deadline for best and final offers is 12 noon on 19 July 2024.

For more on these opportunities, visit:

Gatleys Pharmacy in Bolton -
Haslams Pharmacy in Bolton -
Rigbys Chemist in Bolton -
Howards Pharmacy in Bolton -
Paradise Street Pharmacy in Accrington -


For further information on this press release, contact:
Phoebe Burrows, Corporate Communications Manager
P: 07540 063 598 or E:

Contact the agent:
Tom Young, Business Agent – Pharmacy
P: 07831 133 642 or E:

Visit Christie & Co’s Business Search page to find out more about current medical listings.

Related Articles

View other related news and insights